Gordon Murdo 4
4 · AMGEN INC · Filed May 9, 2024
Insider Transaction Report
Form 4
AMGEN INCAMGN
Gordon Murdo
EVP, Global Commercial Ops
Transactions
- Award
Common Stock
2024-05-07+3,529→ 52,674 total - Award
Nqso (Right to Buy)
2024-05-07$300.30/sh+22,930$6,885,879→ 45,860 totalExercise: $300.30From: 2026-05-07Exp: 2034-05-07→ Common Stock (22,930 underlying)
Footnotes (4)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.
- [F2]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,419 RSUs which will vest on 4/30/2025; 2,902 which will vest in installments of 1,429 on 5/2/2025, and 1,473 on 5/2/2026; 4,237 RSUs which will vest in two installments of 1,398 each on 5/2/2025 and 5/2/2026, and one installment of 1,441 on 5/2/2027; and 3,529 RSUs which will vest in installments of 1,164 on 5/7/2026, 1,165 on 5/7/2027, and 1,200 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 490 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F4]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.